Rawcliffe Adrian Insider Trading
Get the latest insider transactions of Rawcliffe Adrian. Rawcliffe Adrian is CEO and CFO in Adaptimmune Therapeutics PLC ($ADAP) and Chief Executive Officer in Adaptimmune Therapeutics PLC ($ADAP) and Chief Financial Officer in Adaptimmune Therapeutics PLC ($ADAP) and Director in Wave Life Sciences Ltd. ($WVE). Discover the current value of Rawcliffe Adrian shares.
Address: 980 GREAT WEST ROAD BRENTFORD, MIDDLESEX, ENGLAND TW9 9GS
Rawcliffe Adrian is Insider in these Companies
Ticker | Company Name | Current and Previous Positions | Total Shares | Current Value ($) |
---|---|---|---|---|
ADAP | Adaptimmune Therapeutics PLC | Chief Executive Officer, CEO and CFO, Chief Financial Officer | 3,058 | 13,852.74 |
WVE | Wave Life Sciences Ltd. | Director | 0 | 0.00 |
Insider Trading Transactions of Rawcliffe Adrian
Date | Ticker | Company | Owner | Relationship | Transaction | Cost ($) | Shares | Transaction Value ($) | Total Shares |
---|---|---|---|---|---|---|---|---|---|
Jun 28 2021 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Sell | 4.37 | 2,794 | 12,210 | 3,058 |
Jan 19 2021 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Sell | 5.67 | 9,879 | 56,009 | 13,529 |
Jan 12 2021 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Sell | 6.15 | 2,707 | 16,654 | 3,695 |
Jan 11 2021 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Option Exercise | 1.03 | 3,260,400 | 3,358,212 | 3,260,400 |
Jan 11 2021 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Option Exercise | 0.00 | 728,160 | 1,019 | 728,160 |
Jan 05 2021 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Sell | 5.33 | 4,967 | 26,464 | 6,737 |
Sep 02 2020 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Sell | 8.51 | 2,776 | 23,637 | 3,076 |
Aug 20 2020 | WVE | Wave Life Sciences Ltd. | Rawcliffe Adrian | Director | Option Exercise | 9.13 | 10,500 | 95,865 | 10,500 |
Aug 04 2020 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Sell | 9.25 | 2,788 | 25,789 | 3,064 |
Jan 17 2020 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Option Exercise | 0.74 | 2,515,536 | 1,861,497 | 2,515,536 |
Jan 17 2020 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Option Exercise | 0.00 | 561,792 | 730 | 561,792 |
Jan 15 2020 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Sell | 5.13 | 3,236 | 16,616 | 3,166 |
Jan 07 2020 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Executive Offic ... | Sell | 1.20 | 5,900 | 7,080 | 5,804 |
Sep 03 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | CEO and CFO | Option Exercise | 0.27 | 628,872 | 169,795 | 628,872 |
Sep 03 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | CEO and CFO | Option Exercise | 0.27 | 628,872 | 169,795 | 628,872 |
Sep 03 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | CEO and CFO | Option Exercise | 0.00 | 140,448 | 169 | 140,448 |
Sep 03 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | CEO and CFO | Option Exercise | 0.00 | 140,448 | 169 | 140,448 |
Aug 16 2019 | WVE | Wave Life Sciences Ltd. | Rawcliffe Adrian | Director | Option Exercise | 20.34 | 10,500 | 213,570 | 10,500 |
Aug 16 2019 | WVE | Wave Life Sciences Ltd. | Rawcliffe Adrian | Director | Option Exercise | 20.34 | 10,500 | 213,570 | 10,500 |
Jun 27 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 0.68 | 628,872 | 427,633 | 628,872 |
Jun 27 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 0.00 | 140,448 | 183 | 140,448 |
Jan 16 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Sell | 5.37 | 3,084 | 16,559 | 3,318 |
Jan 08 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 0.89 | 1,257,744 | 1,119,392 | 1,257,744 |
Jan 08 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 0.89 | 1,257,744 | 1,119,392 | 1,257,744 |
Jan 08 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 0.00 | 280,896 | 365 | 280,896 |
Jan 08 2019 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 0.00 | 280,896 | 365 | 280,896 |
Aug 15 2018 | WVE | Wave Life Sciences Ltd. | Rawcliffe Adrian | Director | Option Exercise | 46.70 | 9,000 | 420,300 | 9,000 |
Mar 22 2018 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Sell | 1.71 | 600,000 | 1,026,000 | 0 |
Jan 17 2018 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 1.30 | 687,984 | 894,379 | 687,984 |
Jan 17 2018 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 0.00 | 153,648 | 215 | 153,648 |
Aug 17 2017 | WVE | Wave Life Sciences Ltd. | Rawcliffe Adrian | Director | Option Exercise | 18.10 | 9,000 | 162,900 | 9,000 |
Feb 01 2017 | WVE | Wave Life Sciences Ltd. | Rawcliffe Adrian | Director | Option Exercise | 28.80 | 18,000 | 518,400 | 18,000 |
Jan 18 2017 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 0.72 | 2,072,976 | 1,492,543 | 2,072,976 |
Jan 20 2016 | ADAP | Adaptimmune Therapeutics ... | Rawcliffe Adrian | Chief Financial Offic ... | Option Exercise | 1.27 | 939,948 | 1,195,332 | 939,948 |